Author

Philippe Bertrand

Centre National de la Recherche ScientifiquePrimary ORCID profile (0000-0001-8269-6977 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Philippe BertrandiD1 paper · Université Paris Cité

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Antoine Richieu· 1 shared Carole BourquiniD· 1 shared Fedaa AttanaiD· 1 shared Isabel F. CoiraiD· 1 shared Muriel CuendetiD· 1 shared Muriel UrwyleriD· 1 shared Rafael RincóniD· 1 shared Shozeb M HaideriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Antoine Richieu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Selective molecular inhibition of the HDAC6 ZnF-UBP binding domain impairs multiple myeloma cell proliferation

Rafael Rincón, Isabel F. Coira, Antoine Richieu, Fedaa Attana, Muriel Urwyler, Shozeb M Haider, Carole Bourquin, Philippe Bertrand, Muriel Cuendet

This study shows that inhibiting the ZnF-UBP domain of HDAC6 in multiple myeloma cells reduces proliferation and aggresome formation, suggesting it as a therapeutic target.

Cell Death Discovery · Apr 15, 2025Peer-reviewedCancer Biology